Researchers also examined major adverse CV events in patient subgroups on the basis of major adverse CV event rates in the placebo group, the presence or absence of CVD, HbA1c level, trial duration, treatment dosing interval, structural homology to human GLP-1 or exendin-4, BMI, age and eGFR
BaronioFRighiBRighettiFBettocchiIOrtolanoRFaldellaGet al
The glycine already in Red Rock formulations provides a baseline of amino acid support
People stop tirzepatide for many reasons cost, insurance changes, medication shortages, reaching a goal weight, pregnancy planning, or simply wanting to try maintaining results on their own
The primary concern isn't safety but efficacy
Use effective contraception while on therapy and book a pre-conception review to plan a safe transition